• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APPLIED MEDICAL RESOURCES EB010, VOYANT 5MM FUSION 37CM, 6/BX; GEI

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APPLIED MEDICAL RESOURCES EB010, VOYANT 5MM FUSION 37CM, 6/BX; GEI Back to Search Results
Model Number EB010
Medical Device Problem Code Energy Output Problem (1431)
Health Effect - Clinical Code No Information (3190)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
No product is being returned for evaluation and no lot # has been provided to manufacturer.A final report will be sent once the results have been analyzed.
 
Event or Problem Description
Procedure performed: unknown.Following a meeting with theatre manager on 9th november 2018, i was informed that the patient from previous incident was returned to theatre following procedure on (b)(6) 2018.This was recorded via datix.Theatre manager did not provide further details when asked regarding circumstances of patients return to theatre.Patient status is unknown.Additional information has been requested but as of today, 19 november, it was not possible to gather more.Patient status: unknown.
 
Additional Manufacturer Narrative
The event unit was not returned to applied medical for evaluation.As the event unit was not returned, testing was unable to be performed and the complainant¿s experience could not be replicated or confirmed.In the absence of the event unit, it is difficult to determine the exact root cause of the event.Applied medical will continue to monitor its vigilance system for trends and take appropriate actions, as necessary, to ensure the performance and safety of its products.
 
Event or Problem Description
Date of incident is unknown.Following a meeting with theatre manager, on 9th november 18, i was informed that the patient from previous incident was returned to theatre following procedure on (b)(6) 2018.This was recorded via datix.Theatre manager did not provide further details when asked regarding circumstances of patients return to theatre.Patient status is unknown additional information has been requested but as of today, 19 november, it was not possible to gather more.Clarification from rep received 17dec2018: the answer to your question; according to the information given to me by the theatre manager, on the 8th november 2018.Following the procedure on (b)(6) 2018, that patient returned back to theatre soon after (i don¿t know the date) for an unspecified reason.Theatre manager told me that he had heard a comment from hospital rep that implied it was due to the voyant.Because of this comment, i submitted a cer to report the additional information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EB010, VOYANT 5MM FUSION 37CM, 6/BX
Common Device Name
GEI
Manufacturer (Section D)
APPLIED MEDICAL RESOURCES
22872 avenida empresa
rancho santa margarita CA 92688
MDR Report Key8158381
Report Number2027111-2018-00465
Device Sequence Number244082
Product Code GEI
UDI-Device Identifier00607915117856
UDI-Public(01)00607915117856(17)190817(30)01(10)1317789
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K141288
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 01/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/17/2019
Device Model NumberEB010
Device Catalogue Number101462801
Device Lot Number1317789
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 11/09/2018
Supplement Date Received by Manufacturer11/09/2018
Initial Report FDA Received Date12/12/2018
Supplement Report FDA Received Date01/29/2019
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization;
-
-